Serotonin Uptake Inhibitors
"Serotonin Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
| Descriptor ID |
D017367
|
| MeSH Number(s) |
D27.505.519.562.437.850 D27.505.519.625.600.850 D27.505.519.625.850.900 D27.505.696.577.600.850 D27.505.696.577.850.900
|
| Concept/Terms |
Serotonin Uptake Inhibitors- Serotonin Uptake Inhibitors
- 5-Hydroxytryptamine Uptake Inhibitors
- 5 Hydroxytryptamine Uptake Inhibitors
- Inhibitors, 5-HT Uptake
- Inhibitors, 5 HT Uptake
- Inhibitors, 5-Hydroxytryptamine Uptake
- Inhibitors, 5 Hydroxytryptamine Uptake
- Inhibitors, Serotonin Reuptake
- Reuptake Inhibitors, Serotonin
- Serotonin Reuptake Inhibitors
- Uptake Inhibitors, 5-HT
- Uptake Inhibitors, 5 HT
- Uptake Inhibitors, 5-Hydroxytryptamine
- Uptake Inhibitors, 5 Hydroxytryptamine
- Uptake Inhibitors, Serotonin
- 5-HT Uptake Inhibitors
- 5 HT Uptake Inhibitors
- Inhibitors, Serotonin Uptake
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Uptake Inhibitors".
This graph shows the total number of publications written about "Serotonin Uptake Inhibitors" by people in this website by year, and whether "Serotonin Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2002 | 2 | 2 | 4 |
| 2003 | 4 | 3 | 7 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 3 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 3 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2016 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin Uptake Inhibitors" by people in Profiles.
-
Tarfa RA, Melder K, Mady LJ, Eibling D. Is mandibular osteomyelitis a sequela of SSRI-induced dental implant failure? A systematic review & case report. Am J Otolaryngol. 2022 Jan-Feb; 43(1):103236.
-
Fillingham YA, Hanson TM, Leinweber KA, Lucas AP, Jevsevar DS. Generalized Anxiety Disorder: A Modifiable Risk Factor for Pain Catastrophizing After Total Joint Arthroplasty. J Arthroplasty. 2021 07; 36(7S):S179-S183.
-
Naples JG, Kotlarczyk MP, Perera S, Greenspan SL, Hanlon JT. Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women. Am J Geriatr Psychiatry. 2016 12; 24(12):1221-1227.
-
Kurlansik SL, Maffei MS. Somatic Symptom Disorder. Am Fam Physician. 2016 Jan 01; 93(1):49-54.
-
Stidd DA, Vogelsang K, Krahl SE, Langevin JP, Fellous JM. Amygdala deep brain stimulation is superior to paroxetine treatment in a rat model of posttraumatic stress disorder. Brain Stimul. 2013 Nov; 6(6):837-44.
-
Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013 Apr 03; 309(13):1359-67.
-
Tepper SJ. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice. Headache. 2012 Feb; 52(2):195-7.
-
Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, Griggs JJ, Hayes DF. Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer. 2011 Dec 15; 117(24):5469-75.
-
Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011; 11(1):1-11.
-
Irwin D, Lippa CF, Rosso A. Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen. 2010 Nov; 25(7):566-71.